The antibiotic Raxar was approved in November 1997 despite evidence from clinical studies suggesting it could cause several fatal heart-rhythm disruptions. Click on FAQ on Arrhythmia: Raxar, to learn more about this issue.
When Raxar clinical trials came under review by the FDA, a medical officer suspected that two out of four patients who died after taking Raxar in clinical trials possibly suffered heart-rhythm disturbances caused by the drug. FDA officials, however, chose...MORE >>
| | |
1.The Drug Lords : America's... |
2.Deadly Drug Interactions : The People's... |
3.The Pdr Family Guide to Prescription... |
4.The Essential Guide to Prescription... |
5.2001 Mosby's GenRx: A Comprehensive... |
6.The American Pharmaceutical... |
|
The above is not legal advice. That can only come from a qualified attorney who is familiar with all the facts and circumstances of a particular, specific case and the relevant law. See Terms of Use. |